(MedPage Today) — The FDA approved extended-release diazoxide choline (Vykat XR) to treat the intense persistent sensation of hunger in patients 4 years of age and older with Prader-Willi syndrome, maker Soleno Therapeutics announced. “The FDA… Source link : https://www.medpagetoday.com/endocrinology/growthdisorders/114856 Author : Publish date : 2025-03-27 18:35:00 Copyright for syndicated content belongs to the linked […]
The post FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome first appeared on News Health.
Author : News Health
Publish date : 2025-03-27 18:35:00
Copyright for syndicated content belongs to the linked Source.